KLRA · Kailera Therapeutics, Inc. · Debt
Market Cap
$1.98B
Shares
129.64M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
2096997
CUSIP
482931102
13F (30d)
77 filings
77 filers
Visit website
Investor relations